Elbasvir/grazoprevir administered for 12 weeks via Percutaneous Endoscopic Gastrostomy Tube Achieves Sustained Virologic Response: A Case Report and a Review of the Literature
Elbasvir/grazoprevir administered for 12 weeks via Percutaneous Endoscopic Gastrostomy Tube Achieves Sustained Virologic Response: A Case Report and a Review of the Literature
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started